Logo for Chimeric Therapeutics Ltd

Chimeric Therapeutics Investor Relations Material

Latest events

Logo for Chimeric Therapeutics Ltd

Status Update

Chimeric Therapeutics
Logo for Chimeric Therapeutics

Status Update

22 May, 2025
Logo for Chimeric Therapeutics

H1 2025

27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Chimeric Therapeutics Ltd

Access all reports
Chimeric Therapeutics Ltd is a biotechnology company focused on developing cell therapy treatments for cancer. The company specializes in chimeric antigen receptor T-cell (CAR-T) therapies, aiming to harness the immune system to target solid tumors and hematologic malignancies. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.